Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Infectious Disease
•
Travel and Tropical Medicine
What is your approach to the duration of antiparasitic therapy for treatment of subarachnoid neurocysticercosis?
Related Questions
Do you treat subarachnoid neurocysticercosis with albendazole alone, or with addition of praziquantel?
Are there clinical circumstances in which there is a role for steroids in treatment of calcified neurocysticercosis associated with perilesional edema and seizures?
Do you routinely refer all patients with cutaneous leishmaniasis with a species associated with mucocutaneous leishmaniasis to ENT for comprehensive nasal/oropharyngeal evaluation, or do you refer only if mucocutaneous involvement is suspected based on careful clinical assessment and/or bedside exam?
What is your approach to monitoring patients with the indeterminate form of Chagas disease?
In patients taking biologics who are planning joint replacement and are known MRSA carriers do you perform decolonization prior to surgery?
How do you approach a well controlled HIV patient with diffuse cutaneous kaposi sarcoma who failed to respond to radiation, paclitaxel and monthly liposomal doxorubicin?
Is there a role for secondary CMV prophylaxis in solid organ transplant patients?
Do you treat patients with HIV-AIDS and positive cryptococcal antigenemia but negative CSF cryptococcal antigen with standard meningitis treatment given the potential for the postzone effect?
How long do you treat an isolated bacterial liver abscess which has either undergone percutaneous drainage or for which an indwelling drain is placed?
How do you approach treatment of tuberculous scleritis in pregnancy?
